These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3724881)

  • 1. [Malignant hyperthermia: case-finding of subjects at risk].
    Viering WA; Sengers RC; Stadhouders AM; Gielen MJ; Festen C
    Ned Tijdschr Geneeskd; 1986 May; 130(22):1002-4. PubMed ID: 3724881
    [No Abstract]   [Full Text] [Related]  

  • 2. [Malignant hyperthermia].
    Gallo P; Iafrate E
    Recenti Prog Med; 1977 Mar; 62(3):239-61. PubMed ID: 141071
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant hyperthermia].
    Nalda MA; González-Machado JL
    Med Clin (Barc); 1985 Jan; 84(2):74-7. PubMed ID: 2983154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current data on the screening of malignant hyperthermia during anesthesia].
    Krivosic-Horber R; Adnet P
    Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects in the clinical picture of malignant hyperthermia (author's transl)].
    Junger H; Kuhnle P; Schorer R
    Z Kinderchir Grenzgeb; 1980 May; 30(1):35-7. PubMed ID: 7456684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.
    Britt BA
    N Engl J Med; 1974 May; 290(20):1140-2. PubMed ID: 4274465
    [No Abstract]   [Full Text] [Related]  

  • 7. "Noninvasive" testing for malignant hyperthermia susceptibility.
    Allen PD; López JR
    Anesthesiology; 2002 Nov; 97(5):1045-6. PubMed ID: 12411783
    [No Abstract]   [Full Text] [Related]  

  • 8. Etiology and pathophysiology of malignant hyperthermia.
    Britt BA
    Fed Proc; 1979 Jan; 38(1):44-8. PubMed ID: 759238
    [No Abstract]   [Full Text] [Related]  

  • 9. Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia.
    López JR; López M; Allen P
    Acta Cient Venez; 1990; 41(2):135-7. PubMed ID: 2135562
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcium content and contracture in isolated muscle of malignant hyperthermia in pigs.
    Nelson TE; Chausmer AB
    J Pharmacol Exp Ther; 1981 Oct; 219(1):107-11. PubMed ID: 7288598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neurological aspects of malignant hyperthermia. Clinics, physiopathology, genetics].
    Serratrice G; Kozak-Ribbens G; Cozzone PJ
    Rev Neurol (Paris); 1997 Jun; 153(5):304-13. PubMed ID: 9296164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ca2+]i in muscles of malignant hyperthermia susceptible pigs determined in vivo with Ca2+ selective microelectrodes.
    Lopez JR; Alamo LA; Jones DE; Papp L; Allen PD; Gergely J; Sréter FA
    Muscle Nerve; 1986 Jan; 9(1):85-6. PubMed ID: 3951486
    [No Abstract]   [Full Text] [Related]  

  • 13. Porcine malignant hyperthermia: observations on the occurrence of pale, soft, exudative musculature among susceptible pigs.
    Nelson TE; Jones EW; Henrickson RL; Falk SN; Kerr DD
    Am J Vet Res; 1974 Mar; 35(3):347-50. PubMed ID: 4819718
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant hyperthermia (review of the Soviet and foreign literature].
    Dunaevskiĭ VA; Mukovozov IN; Orlov VS
    Vestn Khir Im I I Grek; 1975 Apr; 114(4):126-8. PubMed ID: 1224505
    [No Abstract]   [Full Text] [Related]  

  • 15. [Malignant hyperthermia-results of familial investigations in Austria (author's transl)].
    Sporn P
    Wien Klin Wochenschr Suppl; 1981; 132():1-28. PubMed ID: 6952655
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro contracture tests for susceptibility to malignant hyperthermia.
    Rosenberg H; Reed S
    Anesth Analg; 1983 Apr; 62(4):415-20. PubMed ID: 6829945
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome].
    López JR; Alamo LA; Jones D; Papp L; Allen P; Gergely J; Streter F
    Acta Cient Venez; 1985; 36(1):102-4. PubMed ID: 4090898
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of atypical malignant hyperthermia which presented a typical rise in Ca-induced Ca release after the operation].
    Akashi Y; Sato R; Sato M; Tanito Y; Suzuki H
    Masui; 2006 Dec; 55(12):1493-5. PubMed ID: 17190324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-induced adverse effects and malignant hyperthermia susceptibility: comment on the article by Guis et al.
    Vladutiu G
    Arthritis Rheum; 2007 Feb; 57(1):186-7; author reply 187-8. PubMed ID: 17266123
    [No Abstract]   [Full Text] [Related]  

  • 20. Malignant hyperthermia.
    Glisson SN
    Compr Ther; 1988 Oct; 14(10):33-41. PubMed ID: 3053015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.